Literature DB >> 19938037

Role of thermodynamic and kinetic parameters in gadolinium chelate stability.

Jean-Marc Idée1, Marc Port, Caroline Robic, Christelle Medina, Monique Sabatou, Claire Corot.   

Abstract

In recent years there has been a renewed interest in the physicochemical properties of gadolinium chelates (GC). The aim of this review is to discuss the physicochemical properties of marketed GC with regard to possible biological consequences. GC can be classified according to three key molecular features: 1) the nature of the chelating moiety: either macrocyclic molecules in which Gd(3+) is caged in the preorganized cavity of the ligand, or linear, open-chain molecules; 2) ionicity: the ionicity of the molecule varies from neutral to tri-anionic agents; and 3) the presence or absence of an aromatic lipophilic moiety, which has a profound impact on the biodistribution of the GC. These parameters can also explain why GC differ considerably with regard to their thermodynamic stability constants and kinetic stability, as demonstrated by numerous studies. The concept of thermodynamic and kinetic stability is critically discussed, as it remains somewhat controversial, especially in predicting the amount of free gadolinium that may result from decomplexation of chelates in physiologic or pathologic situations. This review examines the possibility that the high kinetic stability provided by the macrocyclic structure combined with a high thermodynamic stability (reinforced by ionicity for macrocyclic chelates) can minimize the amount of free Gd(3+) released in the body. J. Magn. Reson. Imaging 2009;30:1249-1258. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19938037     DOI: 10.1002/jmri.21967

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  52 in total

Review 1.  The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists.

Authors:  Mariane Le Fur; Peter Caravan
Journal:  Metallomics       Date:  2019-02-20       Impact factor: 4.526

Review 2.  Alternatives to gadolinium-based metal chelates for magnetic resonance imaging.

Authors:  Subha Viswanathan; Zoltan Kovacs; Kayla N Green; S James Ratnakar; A Dean Sherry
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Gadolinium compounds signaling through TLR4 and TLR7 in normal human macrophages: establishment of a proinflammatory phenotype and implications for the pathogenesis of nephrogenic systemic fibrosis.

Authors:  Peter J Wermuth; Sergio A Jimenez
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

4.  Trace element analysis of human urine collected after administration of Gd-based MRI contrast agents: characterizing spectral interferences using inorganic mass spectrometry.

Authors:  Amy J Steuerwald; Patrick J Parsons; John G Arnason; Zhen Chen; C Matthew Peterson; Germaine M Buck Louis
Journal:  J Anal At Spectrom       Date:  2013-06       Impact factor: 4.023

Review 5.  Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence.

Authors:  E Kanal; K Maravilla; H A Rowley
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-22       Impact factor: 3.825

Review 6.  Basic MR relaxation mechanisms and contrast agent design.

Authors:  Luis M De León-Rodríguez; André F Martins; Marco C Pinho; Neil M Rofsky; A Dean Sherry
Journal:  J Magn Reson Imaging       Date:  2015-05-14       Impact factor: 4.813

Review 7.  Distribution and chemical forms of gadolinium in the brain: a review.

Authors:  Tomonori Kanda; Yudai Nakai; Akifumi Hagiwara; Hiroshi Oba; Keiko Toyoda; Shigeru Furui
Journal:  Br J Radiol       Date:  2017-09-28       Impact factor: 3.039

8.  Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine.

Authors:  Amir Ali Rahsepar; Ahmadreza Ghasemiesfe; Kenichiro Suwa; Ryan S Dolan; Monda L Shehata; Monica J Korell; Nivedita K Naresh; Michael Markl; Jeremy D Collins; James C Carr
Journal:  Eur Radiol       Date:  2019-01-07       Impact factor: 5.315

Review 9.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

10.  Target binding improves relaxivity in aptamer-gadolinium conjugates.

Authors:  Elyse D Bernard; Michael A Beking; Karunanithi Rajamanickam; Eve C Tsai; Maria C Derosa
Journal:  J Biol Inorg Chem       Date:  2012-08-19       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.